The Effects of Soy Protein and Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors

The Effects of Soy Protein and/or Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors-a Six Months RCT Among Postmenopausal Women

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00856882

Enrollment

Unknown

Registered

2009-03-06

Start date

2007-10-31

Completion date

Unknown

Last updated

2009-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Cardiovascular Risk

Brief summary

The investigators propose to perform a double-blind, randomized placebo-controlled trial to examine the hypothesis that soy protein with isoflavones could improve glycemic control, insulin sensitivity and decrease cardiovascular risk factors in postmenopausal women with prediabetes.

Interventions

DIETARY_SUPPLEMENTsoy protein

DIETARY_SUPPLEMENTisoflavones

DIETARY_SUPPLEMENTmilk protein

Eligibility

Sex/Gender

FEMALE

Age

46 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* Hong Kong Chinese menopausal women aged 46-70 years with prediabetes or early untreated diabetes

Exclusion criteria

* Women with breast, ovary or other cancers in recent 5-year * Severe renal or liver dysfunction * Women with androgen excess * Smokers * Current use or recent (3-month)use of any drug or treatment for glycemic control, lipid improvement, weight reduction; Subjects with known soy or milk allergy.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026